February 20, 2026 · Form 4 insider transaction
Onyia Jude sold 3,110 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as gift and disclosed on an SEC Form 4, filed 3 days after the transaction.
This transaction represents a gift/charitable contribution effective February 20, 2026. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.